![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Porphyrias, Hepatic - 25 Studies Found
Completed |
: Risk Factors of Porphyria Cutanea Tarda (PCT) : Porphyria Cutanea Tarda : 2005-09-13 |
Completed |
: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2008-01-10 : Drug: Deferasirox 250 mg of deferasirox once daily for 6 months |
Recruiting |
: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2012-04-05 :
|
Recruiting |
: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2011-01-26 : Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |
Active, not recruiting |
: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) : Acute Hepatic Porphyria : 2014-09-11 |
Completed |
: Study of the Pathogenesis of Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2000-04-06 |
Not yet recruiting |
: Harvoni Treatment Porphyria Cutanea Tarda :
: 2017-04-13 : Drug: Harvoni One capsule of Harvoni/ ledipasvir, 90 mg + sofosbuvir, 400 mg administered daily for 8, 1 |
Recruiting |
: Oral Iron for Erythropoietic Protoporphyrias :
|
Recruiting |
: Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact :
|
Recruiting |
: Phase III Confirmatory Study in Erythropoietic Protoporphyria : Erythropoietic Protoporphyria : 2012-05-22 :
|